Skip to main content

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.

Status
recruiting
Phase
Phase 2
Institution
M.D. Anderson Cancer Center
Principal investigator
Moran Amit, MD, PHD
Start date
2025-05-23
End date
2029-03-31
Registry ID
NCT06801041

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.